Pharmaceutical

Bristol Myers Squibb reports 6% drop in Q2 2023 revenues

Bristol Myers Squibb has reported revenues of $11.2bn in the second quarter of 2023, versus $11.8bn in Q2 2022, indicating a drop of 6%.

Jul 29, 2023 - 20:00
Bristol Myers Squibb reports 6% drop in Q2 2023 revenues
Bristol Myers Squibb has reported revenues of $11.2bn in the second quarter of 2023, versus $11.8bn in Q2 2022, indicating a drop of 6%.
Read the original article

Tags:

Previous Article

Carmell to merge with regenerative medicine company Axolotl

Next Article

InSilicoTrials and Axoltis to develop drugs for neurological disorders

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

ProKidney amends Phase III protocol in light of Phase II results

ProKidney amends Phase III protocol in light of Phase I...

Nov 14, 2023

Opinion: After living with sickle cell disease for 39 years, I’m both excited and skeptical about the newly approved gene therapies

Opinion: After living with sickle cell disease for 39 y...

Dec 9, 2023

STAT+: After a lull, the pace of FDA authorization of AI-enabled medical devices is rising

STAT+: After a lull, the pace of FDA authorization of A...

Oct 20, 2023